Amphastar Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Amphastar Pharmaceuticals,

07/05/2021 19:28

* Amphastar Pharmaceuticals Inc  AMPH.OQ  reported quarterly
adjusted earnings of 27 cents​​ per share for the quarter ended
in March. The mean expectation of seven analysts for the quarter
was for earnings of 18 cents per share.
* Revenue rose 21.6% to $103.02 million from a year ago​; 
analysts expected $97.26 million.
* The mean earnings estimate of analysts had risen by about 0.5%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Amphastar Pharmaceuticals Inc shares had fallen by 1.5% this
quarter and lost 10.2% so far this year.
* The company reported quarterly net income of $5.04 million.
* Wall Street's median 12-month price target for Amphastar
Pharmaceuticals Inc is $21.00 
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 2 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 7 at 06:28 p.m. GMT. ​All
figures in US Dollars.​